FR2923719B1 - PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES - Google Patents

PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES

Info

Publication number
FR2923719B1
FR2923719B1 FR0708013A FR0708013A FR2923719B1 FR 2923719 B1 FR2923719 B1 FR 2923719B1 FR 0708013 A FR0708013 A FR 0708013A FR 0708013 A FR0708013 A FR 0708013A FR 2923719 B1 FR2923719 B1 FR 2923719B1
Authority
FR
France
Prior art keywords
pharmaceutical compositions
compositions based
azetidine derivatives
azetidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0708013A
Other languages
French (fr)
Other versions
FR2923719A1 (en
Inventor
Sophie Cote
Maria Teresa Peracchia
Christel Raffournier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Priority to FR0708013A priority Critical patent/FR2923719B1/en
Priority to PA20088803101A priority patent/PA8803101A1/en
Priority to ARP080104946A priority patent/AR069300A1/en
Priority to PCT/FR2008/001594 priority patent/WO2009095560A1/en
Priority to PE2008001920A priority patent/PE20091421A1/en
Priority to UY31473A priority patent/UY31473A1/en
Priority to TW097144247A priority patent/TW200936128A/en
Publication of FR2923719A1 publication Critical patent/FR2923719A1/en
Application granted granted Critical
Publication of FR2923719B1 publication Critical patent/FR2923719B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR0708013A 2007-11-15 2007-11-15 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES Expired - Fee Related FR2923719B1 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0708013A FR2923719B1 (en) 2007-11-15 2007-11-15 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
PA20088803101A PA8803101A1 (en) 2007-11-15 2008-11-06 PHARMACEUTICAL COMPOSITIONS
PCT/FR2008/001594 WO2009095560A1 (en) 2007-11-15 2008-11-13 Pharmaceutical compositions containing azetidine derivatives
PE2008001920A PE20091421A1 (en) 2007-11-15 2008-11-13 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
ARP080104946A AR069300A1 (en) 2007-11-15 2008-11-13 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
UY31473A UY31473A1 (en) 2007-11-15 2008-11-14 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
TW097144247A TW200936128A (en) 2007-11-15 2008-11-14 Pharmaceutical compositions based on azetidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0708013A FR2923719B1 (en) 2007-11-15 2007-11-15 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES

Publications (2)

Publication Number Publication Date
FR2923719A1 FR2923719A1 (en) 2009-05-22
FR2923719B1 true FR2923719B1 (en) 2009-11-20

Family

ID=39327136

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0708013A Expired - Fee Related FR2923719B1 (en) 2007-11-15 2007-11-15 PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES

Country Status (7)

Country Link
AR (1) AR069300A1 (en)
FR (1) FR2923719B1 (en)
PA (1) PA8803101A1 (en)
PE (1) PE20091421A1 (en)
TW (1) TW200936128A (en)
UY (1) UY31473A1 (en)
WO (1) WO2009095560A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2833842B1 (en) * 2001-12-21 2004-02-13 Aventis Pharma Sa PHARMACEUTICAL COMPOSITIONS BASED ON AZETIDINE DERIVATIVES
EP1498123A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Emulsifying systems containing azetidine derivatives
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives

Also Published As

Publication number Publication date
AR069300A1 (en) 2010-01-13
UY31473A1 (en) 2009-07-17
WO2009095560A1 (en) 2009-08-06
FR2923719A1 (en) 2009-05-22
TW200936128A (en) 2009-09-01
PE20091421A1 (en) 2009-10-17
PA8803101A1 (en) 2009-06-23

Similar Documents

Publication Publication Date Title
LTPA2018014I1 (en) Pharmaceutical Composition 514
BRPI0810928A2 (en) "pharmaceutical composition"
BRPI0511900A (en) pharmaceutical compositions
BRPI0810646A2 (en) "PHARMACEUTICAL COMPOUNDS".
RU2398586C3 (en) PHARMACEUTICAL COMPOSITION
ATE481383T1 (en) 3-AZA-BICYCLOÄ3.1.0ÜHEXANE DERIVATIVES
DK1940467T3 (en) Long-release drug composition
DK2073795T3 (en) Abuse-safe drug formulation
NO20075628L (en) Pharmaceutical formulations
BRPI0715712A2 (en) PHARMACEUTICAL COMPOSITION
IL191907A0 (en) Azepinoindole derivatives as pharmaceutical agents
DK1962873T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING OXALATE-REDUCING BACTERIA
BRPI0719393A2 (en) Pharmaceutical Composition
BRPI0613033A2 (en) oral composition
DK1984009T3 (en) Pharmaceutical compositions with improved stability
BRPI0716365A2 (en) "dental article"
DK3492069T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE
ITPN20050014A1 (en) "PERFECTED LEVELER FEET"
DK1957073T3 (en) PHARMACEUTICAL
BRPI0716445A2 (en) pharmaceutical composition
BRPI0720234A2 (en) PHARMACEUTICAL COMPOSITION
DK2918286T3 (en) A PHARMACEUTICAL FORMULATION
DK2271321T3 (en) Pharmaceutical Composition 271
ITFI20080016A1 (en) PHARMACEUTICAL FORMULATIONS ORAL CONTAINING GLYCLAZIDE.
BRPI0913709A2 (en) "pharmaceutical formulation"

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20110801